Analyze Diet
Cell transplantation2016; 25(11); 2017-2026; doi: 10.3727/096368916X691015

MyoD Overexpressed Equine Adipose-Derived Stem Cells Enhanced Myogenic Differentiation Potential.

Abstract: Mesenchymal stem cells could potentially be used in the clinical treatment of muscle disorders and muscle regeneration. Adipose-derived stem cells (ADSCs) can be easily isolated from adipose tissue, as opposed to stem cells of other tissues. We believe that cell therapy using ADSCs could be applied to muscle disorders in horses and other species. We sought to improve the myogenic differentiation potential of equine ADSCs (eqADSCs) using a MyoD lentiviral vector. MyoD lentiviruses were transduced into eqADSCs and selected using puromycin. Cells were cultured in differentiation media containing 5% horse serum, and after 5 days the MyoD-transduced cells differentiated into myogenic cells (MyoD-eqADSCs). Using green fluorescent protein (GFP), MyoD-eqADSCs were purified and transplanted into the tibialis anterior muscles of mice after they were injured with the myotoxin notexin. The mice were sacrificed to examine any regeneration in the tibialis anterior muscle 4 weeks after the MyoD-eqADSCs were injected. The MyoD-eqADSCs cultured in growth media expressed murine and equine MyoD; however, they did not express late differentiation markers such as myogenin (MYOG). When cells were grown in differentiation media, the expression of MYOG was clearly observed. According to our reverse transcription polymerase chain reaction and immunocytochemistry results, MyoD-eqADSCs expressed terminal myogenic phase genes, such as those encoding dystrophin, myosin heavy chain, and troponin I. The MyoD-eqADSCs fused to each other, and the formation of myotube-like cells from myoblasts in differentiation media occurred between days 5 and 14 postplating. In mice, we observed GFP-positive myofibers, which had differentiated from the injected MyoD-eqADSCs. Our approaches improved the myogenic differentiation of eqADSCs through the forced expression of murine MyoD. Our findings suggest that limitations in the treatment of equine muscle disorders could be overcome using ADSCs.
Publication Date: 2016-02-20 PubMed ID: 26892394DOI: 10.3727/096368916X691015Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the potential of using Mesenchymal stem cells, particularly Adipose-derived stem cells (ADSCs), for the treatment of muscle disorders and muscle regeneration. Their approach improves myogenic differentiation – the process of stem cells turning into muscle cells – with the aid of a MyoD lentiviral vector.

Understanding the methodology

  • The researchers extracted adipose-derived stem cells (ADSCs) from equines. These stem cells have the potential to be transformed into cells of various types, in this case, the researchers focus on their differentiation into muscle cells – a process called Myogenesis.
  • They used a MyoD lentiviral vector to enhance the myogenic differentiation potential of the equine ADSCs. MyoD is a protein that plays a crucial role in muscle differentiation, and lentiviral vectors are a type of virus used to deliver genes or proteins into cells. So, they used the lentiviral vector to introduce and overexpress the MyoD in ADSCs and selected the successfully transduced cells using puromycin – an antibiotic used for cell selection.
  • The cells were then cultured in differentiation media for 5 days, after which the MyoD-transduced cells differentiated into myogenic cells.

Investigation

  • The researchers then purified these MyoD-transduced cells using green fluorescent protein (GFP) and transplanted them into mice’s tibialis anterior muscles, previously injured with the myotoxin notexin.
  • Four weeks after the transplantation, the mice were sacrificed in order to study the regeneration in the tibialis anterior muscle. GFP-positive myofibers were spotted, which had differentiated from the injected MyoD-transduced cells, indicating successful myogenesis.
  • The MyoD-transduced cells also exhibited the expression of terminal myogenic phase genes, such as dystrophin, myosin heavy chain, and troponin I, confirming successful myogenic differentiation.
  • These cells also exhibited the formation of myotube-like cells, indicating the progression and maturity of myogenesis.

Conclusion

  • This research suggests that the limitations currently present in the treatment of equine muscle disorders, and potentially in other muscle related disorders, could be overcome with the use of adipose-derived stem cells.
  • The targeted introduction and over-expression of MyoD in these cells greatly improves their myogenic differentiation, making it a promising therapeutic candidate.

Cite This Article

APA
Sung SE, Hwang M, Kim AY, Lee EM, Lee EJ, Hwang SK, Kim SY, Kim HK, Jeong KS. (2016). MyoD Overexpressed Equine Adipose-Derived Stem Cells Enhanced Myogenic Differentiation Potential. Cell Transplant, 25(11), 2017-2026. https://doi.org/10.3727/096368916X691015

Publication

ISSN: 1555-3892
NlmUniqueID: 9208854
Country: United States
Language: English
Volume: 25
Issue: 11
Pages: 2017-2026

Researcher Affiliations

Sung, Soo-Eun
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Hwang, Meeyul
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Kim, Ah-Young
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Lee, Eun-Mi
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Lee, Eun-Joo
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.
Hwang, Su-Kyeong
  • Department of Pediatrics, Kyungpook National University Hospital, Daegu, Republic of Korea.
Kim, Shin-Yoon
  • Skeletal Diseases Genome Research Center, Kyungpook National University Hospital, Daegu, Republic of Korea.
Kim, Hong-Kyun
  • Department of Ophthalmology, Kyungpook National University Hospital, Daegu, Republic of Korea.
Jeong, Kyu-Shik
  • Department of Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Stem Cell Therapeutic Research Institute, Kyungpook National University, Daegu, Republic of Korea.

MeSH Terms

  • Adipose Tissue / cytology
  • Animals
  • Cell Differentiation / physiology
  • Cells, Cultured
  • Dystrophin / metabolism
  • Genetic Vectors / genetics
  • Genetic Vectors / metabolism
  • Horses
  • Lentivirus / genetics
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Muscle Development / physiology
  • Muscle Fibers, Skeletal / cytology
  • Muscle Fibers, Skeletal / metabolism
  • MyoD Protein / genetics
  • MyoD Protein / metabolism
  • Myoblasts / cytology
  • Myoblasts / metabolism
  • Myogenin / genetics
  • Myogenin / metabolism
  • Myosin Heavy Chains / metabolism
  • Stem Cell Transplantation
  • Stem Cells / cytology
  • Stem Cells / metabolism
  • Troponin I / metabolism

Citations

This article has been cited 13 times.
  1. Kankala RK, Han YH, Xia HY, Wang SB, Chen AZ. Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications. J Nanobiotechnology 2022 Mar 12;20(1):126.
    doi: 10.1186/s12951-022-01315-xpubmed: 35279150google scholar: lookup
  2. Sung SE, Seo MS, Kang KK, Choi JH, Lee S, Sung M, Kim K, Lee GW, Lim JH, Yang SY, Yim SG, Kim SK, Park S, Kwon YS, Yun S. Mesenchymal Stem Cell Exosomes Derived from Feline Adipose Tissue Enhance the Effects of Anti-Inflammation Compared to Fibroblasts-Derived Exosomes. Vet Sci 2021 Sep 3;8(9).
    doi: 10.3390/vetsci8090182pubmed: 34564576google scholar: lookup
  3. Ullah HMA, Elfadl AK, Park S, Kim YD, Chung MJ, Son JY, Yun HH, Park JM, Yim JH, Jung SJ, Choi YC, Shin JH, Kim DS, Park JK, Jeong KS. Nogo-A Is Critical for Pro-Inflammatory Gene Regulation in Myocytes and Macrophages. Cells 2021 Jan 31;10(2).
    doi: 10.3390/cells10020282pubmed: 33572505google scholar: lookup
  4. Chen H, Li Z, Lin M, Lv X, Wang J, Wei Q, Zhang Z, Li L. MicroRNA-124-3p affects myogenic differentiation of adipose-derived stem cells by targeting Caveolin-1 during pelvic floor dysfunction in Sprague Dawley rats. Ann Transl Med 2021 Jan;9(2):161.
    doi: 10.21037/atm-20-8212pubmed: 33569463google scholar: lookup
  5. Fei W, Liu M, Zhang Y, Cao S, Wang X, Xie B, Wang J. Identification of key pathways and hub genes in the myogenic differentiation of pluripotent stem cell: a bioinformatics and experimental study. J Orthop Surg Res 2021 Jan 4;16(1):4.
    doi: 10.1186/s13018-020-01979-xpubmed: 33397419google scholar: lookup
  6. Nie F, Bi H, Zhang C, Ding P. Differentiation potential and mRNA profiles of human dedifferentiated adipose cells and adipose‑derived stem cells from young donors. Mol Med Rep 2021 Jan;23(1).
    doi: 10.3892/mmr.2020.11685pubmed: 33200799google scholar: lookup
  7. Liu CG, Han YH, Kankala RK, Wang SB, Chen AZ. Subcellular Performance of Nanoparticles in Cancer Therapy. Int J Nanomedicine 2020;15:675-704.
    doi: 10.2147/IJN.S226186pubmed: 32103936google scholar: lookup
  8. Seo E, Kang H, Lim OK, Jun HS. Supplementation with IL-6 and Muscle Cell Culture Conditioned Media Enhances Myogenic Differentiation of Adipose Tissue-Derived Stem Cells through STAT3 Activation. Int J Mol Sci 2018 May 24;19(6).
    doi: 10.3390/ijms19061557pubmed: 29882916google scholar: lookup
  9. Patruno M, Gomiero C, Sacchetto R, Topel O, Negro A, Martinello T. Tat-MyoD fused proteins, together with C2c12 conditioned medium, are able to induce equine adult mesenchimal stem cells towards the myogenic fate. Vet Res Commun 2017 Sep;41(3):211-217.
    doi: 10.1007/s11259-017-9692-ypubmed: 28589421google scholar: lookup
  10. Guo Y, Wang J, Zhu M, Zeng R, Xu Z, Li G, Zuo B. Identification of MyoD-Responsive Transcripts Reveals a Novel Long Non-coding RNA (lncRNA-AK143003) that Negatively Regulates Myoblast Differentiation. Sci Rep 2017 Jun 6;7(1):2828.
    doi: 10.1038/s41598-017-03071-7pubmed: 28588232google scholar: lookup
  11. Laurindo LF, Lima EP, Araújo AC, Dogani Rodrigues V, Dias JA, Barbosa Tavares Filho M, Zuccari DAPC, Fornari Laurindo L, Miglino MA, Chagas EFB, Gregório Mendes C, Direito R, Valenti VE, Barbalho SM. Targeting Muscle Regeneration with Small Extracellular Vesicles from Adipose Tissue-Derived Stem Cells-A Review. Cells 2025 May 9;14(10).
    doi: 10.3390/cells14100683pubmed: 40422186google scholar: lookup
  12. Carpenter AL, Townsend KS, Johnson PJ, Kim DY. Disseminated pleomorphic rhabdomyosarcoma in a horse. J Vet Diagn Invest 2025 Jan;37(1):203-207.
    doi: 10.1177/10406387241281914pubmed: 39301962google scholar: lookup
  13. Roberts EL, Abraham BD, Dang T, Gysel E, Mehrpouyan S, Alizadeh AH, Koch TG, Kallos MS. Computer controlled expansion of equine cord blood mesenchymal stromal cells on microcarriers in 3 L vertical-wheel(®) bioreactors. Front Bioeng Biotechnol 2023;11:1250077.
    doi: 10.3389/fbioe.2023.1250077pubmed: 37929186google scholar: lookup